Zai Lab (ZLAB) Total Current Liabilities (2016 - 2026)
Zai Lab's (ZLAB) quarterly Total Current Liabilities came in at $393.0 million in Q1 2026, up 22.88% year-on-year from $319.8 million in Q1 2025, and down 5.57% quarter-over-quarter from $416.2 million in Q4 2025.
Zai Lab (ZLAB) Total Current Liabilities (2016 - 2026) Analysis & Trends
Zai Lab has disclosed Total Current Liabilities across 11 years of filings, most recently posting $393.0 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $393.0 million, up 22.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $393.0 million (up 22.88% YoY), and the FY2025 annual result was $416.2 million, up 39.01% from the prior year.
- Total Current Liabilities came in at $393.0 million for Q1 2026 at Zai Lab, down from $416.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $416.2 million in Q4 2025 to a low of $124.6 million in Q1 2023.
- The 5-year median for Total Current Liabilities is $203.1 million (2023), against an average of $238.5 million.
- Across the five-year window, Total Current Liabilities slipped 27.51% in 2022 and surged 129.24% in 2024, its largest moves.
- Zai Lab's Total Current Liabilities stood at $139.8 million in 2022, then soared by 45.21% to $203.1 million in 2023, then surged by 47.43% to $299.4 million in 2024, then jumped by 39.01% to $416.2 million in 2025, then fell by 5.57% to $393.0 million in 2026.
- The last three Total Current Liabilities figures came in at $393.0 million (Q1 2026), $416.2 million (Q4 2025), and $359.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 392.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 392.98 Mn |
| Dec 31, 2025 | 416.17 Mn |
| Sep 30, 2025 | 359.77 Mn |
| Jun 30, 2025 | 331.50 Mn |
| Mar 31, 2025 | 319.81 Mn |
| Dec 31, 2024 | 299.39 Mn |
| Sep 30, 2024 | 286.32 Mn |
| Jun 30, 2024 | 251.72 Mn |
| Mar 31, 2024 | 192.11 Mn |
| Dec 31, 2023 | 203.07 Mn |
| Sep 30, 2023 | 124.90 Mn |
| Jun 30, 2023 | 133.35 Mn |
| Mar 31, 2023 | 124.56 Mn |
| Dec 31, 2022 | 139.84 Mn |
| Sep 30, 2022 | 155.55 Mn |
| Jun 30, 2022 | 168.88 Mn |
| Mar 31, 2022 | 154.91 Mn |
| Dec 31, 2021 | 192.90 Mn |
| Sep 30, 2021 | 112.01 Mn |
| Jun 30, 2021 | 193.92 Mn |